A multinational study shed light on which sites to scan for early signs of the disease, but scoring system was less sensitive ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

In a report released today, from Oppenheimer maintained a Buy rating on Amgen, with a price target of $380.00. The company’s shares closed yesterday at $300.08. Elevate Your Inv ...

Truist Financial analyst Srikripa Devarakonda maintained a Hold rating on Amgen today. The company’s shares closed yesterday at $300.08. Elevate Your Investing Strategy: Take ad ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict ...

We read with interest the Correspondence by Zhiqi Yao and colleagues1 published in The Lancet Diabetes & Endocrinology, which ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

In their letter, the activists told Avantor directors, who are led by chairman Bruce Peacock, former CEO of Amgen, that a ...